Teza Capital Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Teza Capital Management's BIIB Position: Q2 2025 in Review
Teza Capital Management sold out of Biogen (BIIB) in Q2 2025, closing a stake of 2,551 shares — an estimated $349K sold.
Teza Capital Management first reported a position in BIIB in Q4 2017 and held it in 16 quarters. The position peaked at $2.74M in Q3 2023. 866 funds tracked by Wall St. Rank hold BIIB as of Q2 2025.
- Teza Capital Management reported no remaining Biogen position as of Q2 2025 after selling out during the quarter.
- Teza Capital Management sold 2,551 Biogen shares in Q2 2025, an estimated $349K.
- Teza Capital Management first reported a position in Biogen in Q4 2017 and held it in 16 quarters.
- Teza Capital Management's Biogen position peaked at $2.74M in Q3 2023.
- 866 funds tracked by Wall St. Rank held Biogen as of Q2 2025.
Based on Teza Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.